Takeda launches mobile application to support the patient for treatment of genetic diseases
Posted inHealthcare Highlight News

Takeda launches mobile application to support the patient for treatment of genetic diseases

The XPERT EASE App will support HCPs with dose calculation for the treatment of patients with  Lysosomal Storage Disorders Takeda India, part of the Takeda Pharmaceutical Company Limited, a global values-based, R&D-driven biopharmaceutical leader, launched the 'XPERT EASE' application. The application is developed for the exclusive use of healthcare professionals…
Takeda Named Top Employer in India
Posted inBusiness Highlight News

Takeda Named Top Employer in India

Takeda also Named Global Top Employer for Fourth Year Running Takeda India has been named a Top Employer in 2021 by Top Employers Institute. This is also the fourth year in a row Takeda has received the prestigious global Top Employer® status. Takeda also received four regional certifications for Asia Pacific,…
Takeda India Contributes ₹1.2Cr to COVID-19 PM Cares Fund
Posted inFeatured News

Takeda India Contributes ₹1.2Cr to COVID-19 PM Cares Fund

The contribution to the PM Cares Fund aims to support patients and the Government to contain the spread of the disease. Takeda India, part of the Takeda Pharmaceutical Company Limited, a global values-based, R&D-driven biopharmaceutical leader, has announced a donation of ₹ 1.2 Crores to the PM Cares Fund to support India's fight…
Andrey Potapov, the New ICMEA Area Head for Takeda
Posted inFeatured News Healthcare

Andrey Potapov, the New ICMEA Area Head for Takeda

Global biopharmaceutical company Takeda announced Andrew Potapov as its Area Head for India, CIS (the Commonwealth of Independent States), the Middle East including Turkey, and Africa (ICMEA). Potapov’s appointment follows Takeda’s recent acquisition of Shire Pharmaceuticals–enabling Takeda to become a global, values-based, R&D-driven biopharmaceutical leader headquartered in Japan. Potapov will…